Apheresis Equipment Market Share to Outstrip $3.85 Billion, Globally, by 2028 with 8% CAGR – Growth Report by The Insight Partners
February 09, 2023 09:47 ET
|
The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Apheresis Equipment Market Size, Share, Revenue, Sales and Global Forecast to 2028 - Global Analysis by Product...
International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event
February 02, 2023 08:45 ET
|
International Myeloma Foundation
BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and...
Veterinary Hematology Analyzers Market is expected to grow from USD 850 million in 2022 to USD 1515.9 million by 2030 : GreyViews
January 27, 2023 16:00 ET
|
GreyViews
Pune India, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Provectus Biopharmaceuticals Releases 2023 Stockholder Letter
January 09, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that it had issued a beginning-of-the-year letter for 2023 to the Company’s stockholders, which may be found...
Florida Cancer Specialists & Research Institute Research Breakthroughs Presented at Global Hematology Gathering
December 13, 2022 09:17 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) that is contributing to global advancements in the...
Aptose Announces Updated Clinical Responses, Breadth of Activity, and Safety Across Four Dose Levels of Tuspetinib in Difficult-to-Treat Acute Myeloid Leukemia Populations
December 11, 2022 09:00 ET
|
Aptose Biosciences, Inc.
Company Provides Comprehensive Clinical Update from Phase 1/2 TrialTuspetinib Continues to Deliver Single Agent Responses in r/r AML PatientsTuspetinib Safety and Efficacy Profile may Position Drug to...
International Myeloma Foundation Named Winner of 2022 Amazon Web Services IMAGINE Grant for Nonprofits
December 01, 2022 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced it has been selected as a winner of the 2022 Amazon Web Services (AWS) IMAGINE...
In-Vitro Diagnostics Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
November 15, 2022 06:00 ET
|
Graphical Research
Pune, India, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The global in-vitro diagnostics market size is expected to witness remarkable growth during the forecast period, attributed to growing incidence of...
Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib
November 14, 2022 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting...
Global Plasma Fractionation Market Envisioned to Generate a Revenue of $45,803.2 Million and Grow at a CAGR of 7.0% during the Forecast Period from 2020 to 2027 [165-Pages] | Published by Research DIve
August 29, 2022 09:03 ET
|
Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global plasma fractionation market is anticipated to generate a revenue of $45,803.2 million...